Literature DB >> 16517110

Polysorbate 80 UV/vis spectral and chromatographic characteristics--defining boundary conditions for use of the surfactant in dissolution analysis.

W Peter Wuelfing1, Kathryn Kosuda, Allen C Templeton, Amy Harman, Mark D Mowery, Robert A Reed.   

Abstract

Polysorbate 80 is used in the pharmaceutical industry as an additive to enhance the solubility of non-polar compounds in formulation design and during dissolution analysis. In this paper we present the spectroscopic and chromatographic characteristics for a series of commercially available sources of this non-ionic surfactant. The large UV/vis absorbance and broad chromatographic elution of Polysorbate 80 often makes it difficult to accurately quantitate pharmaceutically active compounds in solutions where the surfactant is present. Boundary conditions have been established where analytical interferences can be avoided in spectrophotometric analysis by choice of analysis wavelength and solution concentrations. Chromatographic method development is also presented enabling the removal of Polysorbate interference in instances where spectroscopic interference is too great.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517110     DOI: 10.1016/j.jpba.2006.01.020

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  11 in total

1.  The influence of polysorbate 80 on the radiochemical synthesis of a PET tracer in the FASTlab.

Authors:  Wai Lam Yip; Sverre Arne Sande; David Grace; Dirk Jan in't Veld; Per Christian Sontum; Tina Solvang; Knut Dyrstad
Journal:  Pharm Res       Date:  2014-10-31       Impact factor: 4.200

2.  Protection of Erwinia amylovora bacteriophage Y2 from UV-induced damage by natural compounds.

Authors:  Yannick Born; Lars Bosshard; Brion Duffy; Martin J Loessner; Lars Fieseler
Journal:  Bacteriophage       Date:  2015-07-24

3.  Adsorption and Leachable Contamination of Flucloxacillin, Cyclosporin and Amiodarone Following Delivery Through an Intravenous Administration Set.

Authors:  Zachary Woodward; Peter Brooks; Bernadette Morris-Smith; Marianne Wallis; Steven M Ogbourne
Journal:  Pharm Res       Date:  2018-04-19       Impact factor: 4.200

4.  Modeling of In Vitro Dissolution Profiles of Carvedilol Immediate-Release Tablets in Different Dissolution Media.

Authors:  Duygu Yilmaz Usta; Tuba Incecayir
Journal:  AAPS PharmSciTech       Date:  2022-07-26       Impact factor: 4.026

Review 5.  HPLC methods for choloroquine determination in biological samples and pharmaceutical products.

Authors:  Yugo Araújo Martins; Talita Mota Gonçalves; Renata F V Lopez
Journal:  Daru       Date:  2021-03-19       Impact factor: 3.117

6.  Inhalable Antitubercular Therapy Mediated by Locust Bean Gum Microparticles.

Authors:  Ana D Alves; Joana S Cavaco; Filipa Guerreiro; João P Lourenço; Ana M Rosa da Costa; Ana Grenha
Journal:  Molecules       Date:  2016-05-28       Impact factor: 4.411

7.  A Reference Standard for Analytical Testing of Erythropoietin.

Authors:  Huiping Tu; Kevin Carrick; Rebecca Potts; Mark Hasselberg; Mark Verdecia; Chris Burns; Ben Cowper; Fouad Atouf
Journal:  Pharm Res       Date:  2022-03-15       Impact factor: 4.200

8.  Novel designed polyoxyethylene nonionic surfactant with improved safety and efficiency for anticancer drug delivery.

Authors:  Chang Li; Chunmeng Sun; Shasha Li; Peng Han; Huimin Sun; Ammar Ouahab; Yan Shen; Yourui Xu; Yerong Xiong; Jiasheng Tu
Journal:  Int J Nanomedicine       Date:  2014-04-28

9.  Identification of aggregates in therapeutic formulations of recombinant full-length factor VIII products by sedimentation velocity analytical ultracentrifugation.

Authors:  J F Healey; E T Parker; P Lollar
Journal:  J Thromb Haemost       Date:  2018-01-11       Impact factor: 5.824

10.  Release studies of undecylenoyl phenylalanine from topical formulations.

Authors:  Anna Olejnik; Aleksandra Glowka; Izabela Nowak
Journal:  Saudi Pharm J       Date:  2018-02-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.